The present invention relates to compounds of the general formula (I)
1
The compounds are useful in the treatment and/or prevention of conditions mediated by nu-clear receptors, in particular the Peroxisome Proliferator-Activated Receptors (PPAR).
本发明涉及一般式(I)的化合物。这些化合物在治疗和/或预防由核受体介导的疾病方面具有用途,特别是
过氧化物酶体增殖物激活受体(
PPAR)。